Alerce Investment Management, L.P. - Q3 2023 holdings

$58.5 Million is the total value of Alerce Investment Management, L.P.'s 6 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .

 Value Shares↓ Weighting
AKBA  AKEBIA THERAPEUTICS INC$18,473,836
+24.6%
16,205,1190.0%31.57%
+63.7%
ANNX  ANNEXON INC$16,652,217
-33.0%
7,056,0240.0%28.46%
-11.9%
AMWL  AMERICAN WELL CORPcl a$12,256,589
-44.3%
10,475,7170.0%20.95%
-26.8%
 AADI BIOSCIENCE INC$7,893,217
-29.2%
1,630,8300.0%13.49%
-7.0%
ASMB  ASSEMBLY BIOSCIENCES INC$1,971,338
-23.0%
2,227,5000.0%3.37%
+1.1%
 AILERON THERAPEUTICS INC$1,262,308
-15.1%
830,4660.0%2.16%
+11.5%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-13
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMERICAN WELL CORP12Q3 202362.9%
ANNEXON INC12Q3 202335.9%
AKEBIA THERAPEUTICS INC12Q3 202331.6%
ASSEMBLY BIOSCIENCES INC12Q3 20238.7%
AADI BIOSCIENCES INC9Q3 202324.1%
AILERON THERAPEUTICS INC8Q3 202214.4%
GLOBAL BLOOD THERAPEUTICS IN8Q3 202223.4%
AILERON THERAPEUTICS INC4Q3 20232.3%
AERPIO PHARMACEUTICALS INC3Q2 20215.2%

View Alerce Investment Management, L.P.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-04
13F-HR2022-05-13
13F-HR2022-02-09
13F-HR2021-11-15

View Alerce Investment Management, L.P.'s complete filings history.

Compare quarters

Export Alerce Investment Management, L.P.'s holdings